A legal breakdown for clinics after an October 2026 report that HHS is readying a temporary measure on peptides.
Recap by typeshit. Full story at JD Supra.
A lawyer named Jeff walks through how his side argues Ozempic, Wegovy and other semaglutide drugs may be linked to NAION, a serious form of sudden vision loss.
Stavros Nicolaou of the Pharmaceutical Task Group wants police to act. SAHPRA says it has seized products and opened criminal cases.
The physician group is pushing back on an FDA plan that would open interim access to unapproved peptides, and wants the White House to block it.
Investigators turned up a warehouse of empty pens and a farm building used as a drug factory, as counterfeit weight loss injection sellers grow more organized.
The HSE drugs group discussed Mounjaro on Tuesday. Today only Saxenda is covered for weight loss, and Lilly has offered a significant price cut.
A short blog pointer noting that different GLP-1 medicines have different uses and suggesting people talk with a provider about which, if any, fits them.
Loading…